The Oslo Acute Reperfusion Stroke Study (OSCAR)

Last updated: January 23, 2024
Sponsor: Oslo University Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Stroke

Cerebral Ischemia

Thrombosis

Treatment

Endovascular treatment

Clinical Study ID

NCT06220981
2015-17637
  • Ages > 18
  • All Genders

Study Summary

Prospective registry of clinical and radiological data in acute ischemic stroke patients after endovascular treatment.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 18 years or older
  • Patients with ischemic stroke and cerebral arterial occlusion treated withendovascular revascularization.
  • All stroke severities and vascular distributions are eligible.
  • Informed written consent signed by the patient, verbal consent from the patient aswitnessed by a non-participating health care person or consent by the signature of thepatient's family must be provided before inclusion. Patients for whom no informedconsent can be obtained will not be included in the study but will be treatedaccording to standard guidelines.

Exclusion

Exclusion criteria:

• Patient not eligible for the study or not available for follow-up assessments (e.g. non-resident).

Study Design

Total Participants: 1500
Treatment Group(s): 1
Primary Treatment: Endovascular treatment
Phase:
Study Start date:
January 10, 2017
Estimated Completion Date:
December 31, 2025

Connect with a study center

  • Oslo University Hospital

    Oslo,
    Norway

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.